Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Deepak, who lives with DR-TB, was treated with the TB medicine bedaquiline. Mumbai, India, 2022. Photo credit: Prem Hessenkamp
Press release
Press release |
13 July 2023
Intellectual property and trade Tuberculosis

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

2 min
After discovering she is HIV positive, Gisela suffered from anxiety, depression and panic attacks. Buenaventura, Colombia, 2016. Photo credit: Marta Soszynska/MSF
Press release
Press release |
13 July 2023
HIV/AIDS Intellectual property and trade
Colombia

Colombia to challenge AIDS drug patents

3 min
MSF nurses giving free consultations to unaccompanied foreign minors in the Paris camp. 2020. Photo credit: Nicolas Guyonnet/MSF
Press release
Press release |
12 July 2023
COVID-19

MSF welcomes pro-access recommendations in European Parliament COVID report

3 min
Child at a vaccination site for nomadic communities, N'Djamena, Chad Photo credit: MSF/Johnny Vianney Bissakonou
Press release
Press release |
12 June 2023
Vaccines

MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old

3 min
MSF Lab Technician, Peter Par Koang, conducts tests in Old Fangak, South Sudan, hospital. Photo credit: Florence Miettaux
Press release
Press release |
26 May 2023
Diagnostics

MSF welcomes important resolution at World Health Assembly to strengthen countries’ disease testing capacity

3 min
Clinician preparing samples for a point-of-care CD4 testing machine, Homa Bay County teaching and referral hospital, Kenya Photo credit: Paul Odongo/MSF
Press release
Press release |
11 May 2023
Diagnostics HIV/AIDS

Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production

3 min
Vials of liposomal amphotericin B (L-AmB) Photo credit: Albert Masias/MSF
Press release
Press release |
03 May 2023
HIV/AIDS

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

4 min
A bottle with bedaquiline. Photo credit: MSF/Alexandra Sadokova
Press release
Press release |
26 April 2023
Tuberculosis

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury